NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 150 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $2.893 million which beat the analyst consensus estimate of $2.678 million by 8.03 percent. This is a 11.64 percent decrease over sales of $3.274 million the same period last year.